S-3 S-3ASR EX-FILING FEES 0000872589 REGENERON PHARMACEUTICALS, INC. 0000872589 2024-10-18 2024-10-18 0000872589 1 2024-10-18 2024-10-18 0000872589 2 2024-10-18 2024-10-18 0000872589 3 2024-10-18 2024-10-18 0000872589 4 2024-10-18 2024-10-18 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-3

REGENERON PHARMACEUTICALS, INC.

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial Effective Date

Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward

Newly Registered Securities
Fees to be Paid 1 Debt Debt Securities 457(r) 0.0001531
Fees to be Paid 2 Equity Common Stock, par value $0.001 per share 457(r) 0.0001531
Fees to be Paid 3 Equity Preferred Stock, par value $0.01 per share 457(r) 0.0001531
Fees to be Paid 4 Other Warrants 457(r) 0.0001531
Fees Previously Paid
Carry Forward Securities
Carry Forward Securities

Total Offering Amounts:

$ 0.00

$ 0.00

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 0.00

Offering Note

1

Omitted pursuant to Form S-3 Instructions to the Calculation of Filing Fee Tables and Related Disclosure 2(A)(iii)(c). An indeterminate aggregate initial offering price, principal amount or number of the securities of each identified class is being registered as may from time to time be offered at indeterminate prices or upon conversion, exchange or exercise of other securities registered hereunder to the extent any such securities are, by their terms, convertible into, or exchangeable or exercisable for, such securities. Securities registered hereunder may be sold either separately or as units comprised of more than one type of security registered hereunder. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities or that are issued in units. In accordance with Rule 456(b) and Rule 457(r), the registrant is deferring payment of all of the registration fees and will pay any applicable registration fees on a "pay as you go" basis. The registrant will calculate the registration fee applicable to an offer of securities pursuant to this registration statement based on the fee payment rate in effect on the date of such fee payment.

2

See Offering Note 1.

3

See Offering Note 1.

4

See Offering Note 1.